1PATEL J B, VALENCIK M L, PRITCHETT A M, et al. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload[ J]. Am J Physiol Heart Circ Physiol, 2005, 289 (2) : H777-H784.
3MARTINEZ-RUMAYOR A, RICHARDS A M, BURNETT J C, et al. Biology of the natriuretic peptides[J]. Am J Cardiol, 2008, 101 (3A) : 3-8.
4YEO K T, WU A H, APPLE F S, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay [J]. Clin Chim Acta, 2003, 338 (1-2) : 107-115.
5AZZAZY H M, CHRISTENSON R H, DUH S H. Stability of B-type natriuretic peptide (BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systems[J]. Clin Chim Acta, 2007, 384 (1-2) : 176-178.
7LIANG F, O'REAR J, SCHELLENBERGER U, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide [ J ]. J Am Coil Cardiol, 2007, 49 (10) : 1071-1078.
8ORDONEZ-LLANOS J, COLLINSON P O, CHRISTENSON R H, Aminoterminal pro-B-type natrinretic peptide : analytic considerations [ J ]. Am J Cardiol, 2008, 101 (3A): 9-15.
9TANG W H, FRANCIS G S, MORROW D A, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure [ J ]. Circulation, 2007, 116 (5): e99-e109.
10HUNT S A, ABRAHAM W T, CHIN M H, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society [ J ] . Circulation, 2005, 112 (12) : e154-e235.
2Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure, Lancet, 1997, 349(9054): 747-752.
3Genth Zotz S, Zotz R J, Sigmund M, et al. MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing. EurJ Heart Fail, 2000, 2 (2): 175-181.
4Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341 (10): 709-717.
5The digitalis investigation group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med, 1997, 336 (8): 525-533.
6Maack C, Elter T, Bohm M. Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprplol. Congest Heart Fail, 2003, 9(5): 263-270.
7Baughuman K New medical therapies for advanced left ventricular dysfunction. Cardiol Clin, 1995, 13(1): 27-34.
7Hildebrandt P,Collinson PO.Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patient[J].Am J Cardiol,2008,101 (3A):25-28.
8Anwaruddin S,Lloyd-jones DM,Baggish A,et al.Renal function,congestive heart failure,and aminoterminal pro-brain natriuretic peptide measurement:results from the proBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study[J].J Am Coll Cardiol,2006,47(1):91-97.
9Ewald B,Ewald D,Thakkinstian A,et al.Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction[J].Intern Med J,2008,38(2):101-103.
10Januzzi JL,Van Kimmenade R,Lainchbury J,et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an international pooled anailsis of 1256 patient:the International Collaborative of NT-proBNP Study[J],Eur Heart J,2006,27(3):330-337.
